Kiltearn Partners LLP Has $28.19 Million Position in Cigna Group $CI

Kiltearn Partners LLP raised its stake in Cigna Group (NYSE:CI) by 8.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 97,800 shares of the health services provider’s stock after buying an additional 7,900 shares during the quarter. Cigna Group accounts for about 5.7% of Kiltearn Partners LLP’s portfolio, making the stock its 5th largest position. Kiltearn Partners LLP’s holdings in Cigna Group were worth $28,191,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. boosted its stake in Cigna Group by 11.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after acquiring an additional 4,738 shares during the last quarter. Maj Invest Holding A S increased its stake in Cigna Group by 2.4% in the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after purchasing an additional 10,042 shares in the last quarter. Providence Capital Advisors LLC increased its stake in Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after purchasing an additional 7,748 shares in the last quarter. National Pension Service raised its holdings in Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after purchasing an additional 21,203 shares during the period. Finally, SCS Capital Management LLC boosted its position in shares of Cigna Group by 39.1% during the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after purchasing an additional 8,609 shares in the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Trading Down 3.5%

Shares of NYSE:CI opened at $271.50 on Monday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $280.71 and its 200 day simple moving average is $283.97. The firm has a market cap of $71.55 billion, a price-to-earnings ratio of 12.24, a PEG ratio of 0.94 and a beta of 0.27.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The firm’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, March 5th. Cigna Group’s payout ratio is currently 28.13%.

Insider Activity

In related news, insider Everett Neville sold 1,719 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on CI shares. Barclays decreased their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a report on Friday, February 6th. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Royal Bank Of Canada decreased their target price on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Robert W. Baird lowered their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a report on Thursday, December 11th. Finally, Leerink Partners raised their price target on Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $330.42.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.